Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis
- PMID: 11147993
Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis
Abstract
In patients with established ankylosing spondylitis (AS) and a healthy control group, plasma levels of IGF-1 and TNF-alpha as well as possible connections with biochemical markers of the bone metabolism, humoral inflammatory activity (ESR, CRP), clinical manifestations, and an established clinical activity score (Bath Ankylosing Spondylitis Activity Index = BASDAI) were examined. In AS-patients (men and women) significantly increased TNF-alpha levels were found. Moreover, patients with enthesopathy showed a significantly more frequent increase of CRP and TNF-alpha levels besides an increased urinary pyridinium cross-link excretion. In addition, a significant positive correlation between TNF-alpha, CRP, BASDAI, and urinary pyridinium cross-link excretion was proved, besides a significant negative correlation of IGF-I to urinary pyridinium cross-links and TNF-alpha levels. Summing up, it may be said that TNF-alpha seems to be a reliable surrogate marker in enthesitis. This was proved so far for IgA and endothelium stimulating angiogenic factor only. Besides, the present results argue against a stimulation of osteogenesis. The catabolic situation under high TNF-alpha and low IGF-1 levels may play an important role in the pathogenesis of osteoporosis in AS.
Similar articles
-
Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.J Rheumatol. 2007 Aug;34(8):1753-9. Epub 2007 Jun 15. J Rheumatol. 2007. PMID: 17610317 Clinical Trial.
-
Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.Rheumatology (Oxford). 2008 Dec;47(12):1775-9. doi: 10.1093/rheumatology/ken385. Epub 2008 Oct 14. Rheumatology (Oxford). 2008. PMID: 18854347
-
[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2451-4. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17156669 Chinese.
-
Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.Scand J Rheumatol. 2007 Mar-Apr;36(2):101-6. doi: 10.1080/03009740600991760. Scand J Rheumatol. 2007. PMID: 17476615
-
[Vitamin D levels in ankylosing spondylitis: does deficiency correspond to disease activity?].Rev Bras Reumatol. 2014 Jul-Aug;54(4):330-4. doi: 10.1016/j.rbr.2014.03.027. Epub 2014 Aug 26. Rev Bras Reumatol. 2014. PMID: 25627231 Review. Portuguese.
Cited by
-
Immune mechanism of low bone mineral density caused by ankylosing spondylitis based on bioinformatics and machine learning.Front Genet. 2022 Nov 18;13:1054035. doi: 10.3389/fgene.2022.1054035. eCollection 2022. Front Genet. 2022. PMID: 36468006 Free PMC article.
-
Association between dynamic exercise therapy and IGF-1 and IGFBP-3 concentrations in the patients with rheumatoid arthritis.Rheumatol Int. 2006 Feb;26(4):309-13. doi: 10.1007/s00296-005-0605-y. Epub 2005 Jun 3. Rheumatol Int. 2006. PMID: 15933856 Clinical Trial.
-
IGF-1 and ADMA levels are inversely correlated in nondiabetic ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.Biomed Res Int. 2014;2014:671061. doi: 10.1155/2014/671061. Epub 2014 Sep 11. Biomed Res Int. 2014. PMID: 25295265 Free PMC article.
-
The Protective Effect of Chrysanthemum indicum Extract against Ankylosing Spondylitis in Mouse Models.Biomed Res Int. 2017;2017:8206281. doi: 10.1155/2017/8206281. Epub 2017 Feb 2. Biomed Res Int. 2017. PMID: 28261616 Free PMC article.
-
Uveitis increases the risk of stroke among patients with ankylosing spondylitis: A nationwide population-based longitudinal study.Front Immunol. 2022 Oct 6;13:959848. doi: 10.3389/fimmu.2022.959848. eCollection 2022. Front Immunol. 2022. PMID: 36275682 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous